... AustraliaReferences1. Nagata S: Apoptosis by death factor. Cell 1997, 88:355-365.2. Takeda K, Yamaguchi N, Akiba H, Kojima Y, Hayakawa Y, Tanner JE, Sayers TJ, Seki N, Okumura K, Yagita ... growth factor, IL-2, mayenhance Tri-mAb therapy of orthotopic kidney cancer.When Tri-mAb alone was used against 10-day-estab-lished kidney cancer, a significant survival advantage of mice was achieved ... Corey A, Iacobucci A, MacLean M, Lo L, Fox NL, Oza AM: A phase 1 study of mapatumumab (fully human monoclonal antibody to TRAIL-R1) in patients with advanced solid malignancies. Clin Cancer...